Výsledky vyhledávání

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(10)

Hope is a strange invention – A Patent of the Heart – In unremitting action Yet never wearing out – —Emily Dickinson It was an ordinary Monday morning at the outpatient oncology clinic. As usual, it was a busy day; the waiting room was crowde

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c868184bdc95450d89e22a9c81b2b8
https://pubmed.ncbi.nlm.nih.gov/19171700

Zobrazit plný text záznamu

The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone

Autor: Riccardo Cellerino, Vitaliano Pieroni, Rosa Rita Silva, Andrea Piga, U. Torresi, Giuseppina Catalano, Amedeo Pancotti, Stefano Cascinu, R. Bascioni, Rodolfo Mattioli, Francesca Giorgi, Vincenzo Catalano, Massimo Marcellini

Publikováno v: Cancer investigation. 21(5)

Adjuvant 5-fluorouracil (5FU) and levamisole (Lev) have been considered standard treatment for stage III colon cancer patients. However, the uncertain contribution of Lev to the efficacy of treatment has led many oncologists to prefer the 5FU/leucovo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14f5ba90a61c51f517369a19ea5bc24
https://pubmed.ncbi.nlm.nih.gov/14628428

Zobrazit plný text záznamu

Plný text ve formátu HTML

A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancer

Autor: M Bavosi, Riccardo Cellerino, Lucio Giustini, Giulio Rossi, L Acito, A. Piga, A Pancotti, Stefano Cascinu, M Del Papa, G Francini, Massimo Marcellini, L Latini, R. Bascioni, Flavia Carle

Publikováno v: British Journal of Cancer
Scopus-Elsevier

With the association of 5-fluorouracil (5-FU) and alpha-interferon (IFN), objective responses as high as 26 63% have been reported in untreated patients with advanced colorectal cancer. However, grade 3-4 toxicity has also been reported. We have cond

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::454db374b2361f869bdf2767ad63f39d
https://pubmed.ncbi.nlm.nih.gov/8826868

Zobrazit plný text záznamu

Granisetron plus dexamethasone in moderately emetogenic chemotherapy: evaluation of activity during three consecutive courses of chemotherapy

Autor: R R, Silva, R, Bascioni, F, Giorgi, L, Acito, L, Giustini, G, De Signoribus, M, Marcellini, E T, Menichetti, L, Giuliodori

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 4(4)

In this study we evaluated the antiemetic activity of a combination of 3 mg granisetron in a short i.v. infusion followed by 12 mg dexamethasone i.v. in 64 patients with cancer receiving moderately emetogenic chemotherapy scheduled in a single day. N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::973ab419c9bffa300045d33c887bedcc
https://pubmed.ncbi.nlm.nih.gov/8829306

Zobrazit plný text záznamu

Continuing medical education through the videotex system in Italy

Autor: A, Piga, F, Graziano, R, Bascioni, M, Di Giuseppe, R, Cellerino

Publikováno v: Journal of cancer education : the official journal of the American Association for Cancer Education. 10(4)

Continuing education for medical doctors is not compulsory in Italy. The link with the university is lost shortly after the final medical examination, and there is no other teaching institution for structured continuing medical education (CME). Dista

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::5443447495618aa318cd1af3e3b6a124
https://pubmed.ncbi.nlm.nih.gov/8924395

Zobrazit plný text záznamu

Impact of hospice and palliative home care on chemotherapy use at the end of life (EOL)

Autor: Francesca Rastelli, R. R. Silva, G. De Signoribus, M. Brugni, Farnoosh Basirat, Francesca Giorgi, L. Giuliodori, Lucio Giustini, S. Mulattieri, R. Bascioni, M. di Pietro Paolo

Publikováno v: Journal of Clinical Oncology. 29:e16611-e16611

e16611 Background: Many cancer patients (pts) receive chemotherapy at the end of life (EOL) with negative effects on quality of life and high economic burden. Palliative care services and hospice facilities became widely available in Italy during the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c45ba67b72b7f7870a99fd0850dacee4
https://doi.org/10.1200/jco.2011.29.15_suppl.e16611

Zobrazit plný text záznamu

Continuity of care for cancer patients at the end of life (EoL)

Autor: Lucio Giustini, D. Iacopini, R. Bisonni, Farnoosh Basirat, Francesca Giorgi, Barbara Esperide, L. Acito, Francesca Rastelli, R. Bascioni

Publikováno v: Journal of Clinical Oncology. 28:6145-6145

6145 Background: The transition from curative to palliative care is a difficult phase in the illness trajectory of many oncologic patients (pts). Change of the health care professionals involved in...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::db8e45109c0dae8b31495fc9579b507f
https://doi.org/10.1200/jco.2010.28.15_suppl.6145

Zobrazit plný text záznamu

Chemotherapy in very elderly cancer patients (85 years and over): A retrospective study

Autor: M. Safi, R. Bascioni, Francesca Giorgi, G. De Signoribus, Lucio Giustini, R. R. Silva

Publikováno v: Journal of Clinical Oncology. 27:e20632-e20632

e20632 Background: Elderly cancer patients (pts) population is expanding due to demographic changes. Currently 2.4 % of Italian population is older than 85, with this group accounting ∼8 % of all cancer pts in our geographic area. Since very elderl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::83c30256f79516af03fe6acd7a38b427
https://doi.org/10.1200/jco.2009.27.15_suppl.e20632

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání